We report the DNA sequences of the heavy and light chain immunoglobulin genes of 11 monoclonal rheumatoid factor (RF)-secreting lines derived from the peripheral blood of two patients with rheumatoid arthritis (RA). It is evident from immunogenetic analysis of these lines that RA-associated RF activity can arise from a wide variety of heavy and light chain genes and gene combinations. Although the RF response from our two patients shows a bias in gene usage toward those genes used to encode monoclonal RF, particularly VkIII, relatively few of these RFs are reactive with the monoclonal antiidiotypes 6B6.6 and 17.109 that define VkIII germline-encoded light chains and the loss of this idiotypic reactivity is clearly related to somatic mutation. Finally, RFs derived from peripheral blood of RA patients show a similar heterogeneity of epitope binding to Fc as that seen for synovium-derived RF and some are clearly different in binding specificity from the restricted RF population found in patients with B cell malignancies. Somatic mutations as well as different VH /VL combinations contribute to the heterogeneity in the binding patterns of these RA-derived RF. (J. Clin. Invest. 1994. 93:852-861.)
Introduction
Rheumatoid factors (RFs),' defined as autoantibodies that bind epitopes on the Fc portion ofIgG ( 1 ), are thought to play a physiologic role in clearance of immune complexes, antigen presentation, and/or B cell regulation in normal individuals (2) (3) (4) (5) (6) . In addition, a high proportion of monoclonal IgM antibodies derived from patients with B cell malignancies and cryoglobulinemia have RF activity (2) . In patients with rheumatoid arthritis (RA), where the presence of RF in serum is a hallmark of the disease, RFs are produced by the rheumatoid synovium and higher titers correlate with more aggressive disease ( 1) . There is also substantial evidence that circulating im- 1 . Abbreviations used in this paper: CDR, complementarity determining region; FR, framework region; H/L, heavy/light (chain); RF, rheumatoid factor; R:S, replacement to silent ratio (of mutations); SS, single-stranded. mune complexes involving RF can be pathogenic in some patients with RA ( 1, 7, 8) .
Immunogenetic studies of the RF response in RA have focused on whether there is a bias in the RF repertoire toward usage of particular V region immunoglobulin genes, i.e., whether RFs are encoded by diverse germline genes, suggesting that the high titers in RA are a result ofpolyclonal B cell activation, or whether they are clonally related and somatically mutated in individual patients, suggesting a more specific antigen driven response (reviewed in reference 9) . This issue can be addressed by analyses of idiotypic and fine structural specificity. Monoclonal RFs from patients with B cell dyscrasias have restricted idiotypic specificities, with 60-80% expressing either the 17.109 or 6B6.6 idiotypes that are markers for the human VkIIIb subgroup gene Humkv 325 and VkIIIa subgroup gene Humkv 328 (2, 10, 11) . These light chains are preferentially associated with members ofthe VH1 and VH4 families, respectively ( 12, 13) . However, the 17.109 and 6B6. 6 idiotypes are expressed on only a small fraction of RF from RA patients (2, 11, 14, 15) , suggesting either that the Humkv 325 and 328 genes are not used to encode a RF response in RA patients, or that somatic mutation of the variable regions has resulted in loss of these idiotypic specificities.
B cell lines producing monoclonal RFs have been derived from both RA peripheral lymphocytes and synovium and their immunoglobulin genes have been characterized (16) (17) (18) (19) (20) , reviewed in reference 9) . Study of these lines has shown that although RFs can be encoded by a diverse repertoire of antibody genes, there does appear to be an overrepresentation of the VH3 heavy chain genes and probably of the VkIIIa and VkIIIb light chain genes (9) . Furthermore, patterns of mutation suggest that some ofthese RFs may be selected by antigen ( 18, 20) . In one study oftwo clonally related RFs from a single individual, the higher affinity for Fc was seen in the more mutated RF of the pair (21) .
In addition to the differences in idiotypic specificity between RFs from patients with B cell malignancies and RA-derived RFs, there are also differences in fine antigenic specificity. We studied monoclonal RFs derived both from synovial and peripheral B cell lines from RA patients and found that they have diverse antigenic specificities not found among malignancy-associated RFs (22, 23) . The basis for these differences might relate to usage ofdiverse genes and gene combinations to encode RFs or, alternatively, to the presence of somatic mutations in the RFs from RA patients.
In this study we further examine the molecular genetic structures of the heavy and light chain genes of 11 IgM RFs derived from the peripheral blood oftwo patients with RA and correlate them with fine antigenic and idiotypic specificity. This study documents that in addition to the heavy/light (H/ L) combinations typical of malignancy-associated RFs, a wide variety ofunique H / L combinations can be used to encode RF somatic mutation is responsible both for loss ofidiotypic activity and for alterations in fine antigenic specificity. The RF response in RA patients therefore reflects diversification mediated both by somatic mutation of genes that are used in the RFs of B cell malignancy and by recruitment of new genes and gene combinations.
Methods
Generation ofB cell lines. Peripheral blood was obtained from two patients with RA as defined by American College of Rheumatology criteria. Both patients had erosive disease and both had active synovitis at the time of venipuncture. Patient R was taking 5 mg of prednisone and was on monthly intramuscular gold. Patient B was taking 5 mg of prednisone daily and 10 mg of methotrexate weekly. Lymphocytes were obtained by Ficoll-Hypaque separation of peripheral blood and were transformed with Epstein-Barr virus as previously described (24, 25) . After 4 d the cells were cloned by limiting dilutions as previously described (24) and the clones were tested for IgM RF activity on purified Fc fragments oftotal human IgG by ELISA as previously described (26 Amplification and isolation ofthe VL and VH gene segments. [1] [2] [3] [4] [5] ,gg of total RNA was reverse transcribed into cDNA using oligo-dT as the primer for the light chains and a primer specific for the 5' region of Cu (ADl1 ) as the primer for the heavy chains. Second-strand synthesis and amplification were performed using the PCR. For the light chains the 3' primer was specific for the 3' end of Ck (AD1O) and the 5' primers were specific either for a conserved region of the VkI leader (for VkI or VkII-BD329) or the VkIII leader sequence (AD3). For the heavy chains the same 3' oligonucleotide used for priming was also used in the PCR reaction. The 5' primers used were specific for the leader sequence or first framework ofVH 1, VH3, or VH4.2 30 cycles of amplification were performed using the following conditions: denaturation at 94°C for 1 min, annealing at 50-55°C for 1 min, extension at 72°C for 2 min. Two independent reverse transcription and PCR reactions were set up for each cell line to decrease the possibility of reverse transcriptase or PCR errors. PCR products were purified on a low melt agarose gel (Sigma Chemical Co., St (27) . Three separate PCR reactions were performed using 1, 10, and 100 ng ofgenomic DNA and the fragments were purified and subcloned as above. A total of 60 clones were sequenced in both directions as above.
Similarly, in order to analyze the six VkIII-encoded light chain sequences from patient R, genomic DNA from R was amplified using the same conserved leader oligomer used in the PCR reactions (AD3) and a conserved 3' flanking region sequence oligomer (AD14) homologous to the Humkv 325, 328, and Vg genes (28, 29) . 30 (Table I) . Fine antigenic specificity of these RFs has been described in detail (23 (Fig. 10 B) to a somatic event. Oligonucleotide probes homologous to the Humkv 325 leader sequence and FR3 were used to PCR amplify genomic DNA from patient R and from Re 12 and Ro47 cell line cDNA. Southern blotting was performed using the amplified DNA and the gels were probed either with the Re 12 CDR I -FR2 oligonucleotide incorporating the deletion (AD25), with an Re 12 CDR1 oligonucleotide incorporating three putative mutations (AD26), or with the Ro47 CDR2 oligonucleotide incorporating two mutations (AD 30). As can be seen in Fig. 10 A, both AD25 and AD26 hybridized only to the Re 12 DNA, while the third oligonucleotide corresponding to Ro47 CDR2 (AD30) hybridized only to Ro47. A VkIII DNA probe hybridized equally to all three PCR products (not shown). This data suggests that the deletion seen in Re 12 is not present in the germline ofpatient R, and may have been somatically acquired.
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Amplification of VHJ and VkIII genefamilies The 51 P1 gene, a member of the VH1 gene family, is used by three cell lines from patient R. There are a number of different genes closely related to 5 lPl, some of which are allelic polymorphisms (35 
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GCAAGGCTTCTGGATAC6CCTTCACCGGCTACTATATGCACTGGGTGCGACAGGCCCCTGGACAA
GCAAGGCTTCTGGATACACCTTCACTAGCTATGCTATGCATTGGGTGCGCCAGGCCCCCGGACAA CDR2 the Ro7, Ro47, R2, or Rel12 heavy chain genes than the 5 1PlI or Hvl LI genes. The heavy chain genes from Ro7 and Ro47 were subsequently obtained by PCR from cell line genomic DNA using AD1 3 and ADI 1 in order to examine the leader introns. When the leader introns were compared with the 5 1 P I intron (36), one difference was found in the Ro7 DNA and six differences in the Ro47 DNA (not shown).' An oligonucleotide probe spanning an area of differences in the Ro47 gene (AD28) was used to hybridize to PCR-amplified patient R genomic DNA and Ro47 cell line DNA. No hybridization was seen for the patient R genomic DNA (Fig. 10 C) , nor were we able to obtain a PCR product from patient R genomic DNA when the AD28 oligomer was used as the 5' primer instead of AD 13 (not shown). Together, these experiments indicate that 5 lP1 is the most likely germline gene for the Ro7 and Ro47 heavy chains. One ofthe new genes we obtained from patient R was found to be highly homologous to the B19 heavy chain gene. Using an oligomer homologous to the leader intron of this gene (AD32), we were able to PCR the homologous gene, 1-13 from patient B (Fig. 5 ) . VkIII genes. Genomic DNA from patient R was amplified with the 5' oligomer AD3 and two 3' oligonucleotides, one homologous to the flanking region of all three VkIII genes of interest (AD 14) , and the other (AD9) homologous to FR3 of Vg. Five independent VkIII genes were obtained multiple times from 30 clones sequenced from four separate PCR-amplified libraries. Three of these were 100% homologous to the previously described Humkv 325, 328, and Vg genes, respectively, and two are newly identified genes that are highly homologous to Humkv 305 (28) and Vg" (29) (Figs. 3 and 11) . ggggctt tgactac is probably a new VkIII gene that may have been generated as the result of a gene conversion event between a Humkv 305-like gene and a Vg" gene ( Fig. ) . The sequence is not a simple chimera of Humkv 305 and Vg" generated as a result of PCR artefact because there are differences between 3A9 and both 305 and Vg" in the coding (Fig. 3) (38, 39) , and RFs using the Vg light chain have been previously described (40) . No previous 6B6.6-reactive antibodies have been reported that are encoded by this gene, but Vg belongs to the VkIIIa subgroup that is highly homologous to Humkv 328 (29) .
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Somatic mutation of Humkv 325 and 328 genes has been described in cDNA libraries generated from RA peripheral blood B cells selected for RF activity and from RA synovium B cells, many of which are presumed to have RF activity (38, 39) . In order to determine whether somatic mutation in our Humkv325-and 328-derived cell lines could account for the absence of reactivity with 17.109 and 6B6.6, we isolated and sequenced germline VkIII genes from patient R. Our findings confirm that patient R has the Humkv 325, 328, and Vg genes in her germline, and that these are the appropriate genes for comparison with the cell line RF light chains. We also incidentally identified two new VkIII germline genes: 3A7, which is possibly a polymorphism of the Vg" gene, and 3A9, which appears to have arisen as the result ofa gene conversion-like event between KII1a and KIMIb subgroup genes.
As shown in Fig. 3 (left tentially informative as it displays only two mutations in the light chain, an isoleucine for a threonine in FR 1 and an aspartic acid for a serine in CDR3, both nonconservative changes. Single amino acid differences may result in the loss of both idiotypic and antigenic specificity (42, 43). It is clear from our findings that loss of reactivity with RF-associated idiotypes need not result in loss of RF activity. Site directed mutagenesis of the expressed B19 light chain may allow us to determine which of the amino acid changes noted here results in loss of 6B6.6 activity.
In addition to VkIII-encoded cell lines, our panel includes two VkI encoded light chain genes and one VkII-encoded gene that is sufficiently unlike the VkII genes that have previously been reported to encode RF (30, 31 ) to allow us to conclude that multiple members ofthis gene family encode for RF specificity. The VkI and VkII gene families are not well characterized in humans, so that a mutational analysis ofthese genes was not feasible. Figure 11 . Deduced amino acid sequences of the known VkIII genes and the two newly identified VkIII genes, 3A7 and 3A9.
The RFs of RA patients appear to use a wider range of heavy chains than the RFs of malignancy. A skewing of the RA-associated RF repertoire toward members ofthe VH3 gene family has been noted previously (9, 36) , but this is not the case in our panel ofnine cell lines from patient R. ofwhich four use a member ofthe VH1 gene family, three use VH4, and only two use VH3. This finding suggests there may be marked heterogeneity in heavy chain gene usage by individual patients as well as differences in usage among patients. It is unlikely that the method used to derive the lines, EBV transformation, affects the repertoire, as most previously characterized RF-secreting lines are also derived by this method. The choice of RF-encoding genes in RA patients may depend on factors such as germline gene repertoire, allelic polymorphisms, and previous antigenic exposure.
Mutation analysis of the VH1-encoded cell line heavy chains indicates that these, like the light chains, have undergone varying degrees of change from the germline. VH1 is a large gene family with only a few well-characterized members. Our PCR-amplified library includes seven new VH 1 genes, one of which, 1-13, is most likely the germline homologue of the B 19 heavy chain. Three of our five VH1-encoded cell lines probably use the 51 P1 gene although the two lines we examined in detail, Ro7 and Ro47, appear to have acquired mutations in the leader intron sequence. Mutations have been reported to occur in the leader intron sequence of mouse immunoglobulin at a rate similar to that found in the V regions, so that the presence of 1 mutation in Ro7 and 6 in the Ro47 86-bp leader introns, respectively, would not be an unexpected finding (41) .
Examination ofthe pattern ofreplacement and silent mutations has been used to evaluate the role of antigen in selection of antibodies (44) . In the four cell lines whose heavy and light chain germline origins we can identify with greatest confidence (Ro7, Ro47, Re 12, and B 19), analysis of the pattern of R:S ratios of mutations reveals a variable pattern. Most of our lines do not have more replacement mutations in the CDRs than would be generated by random mutation. The B 19 line, for example, has a high R:S ratio in the CDRs for the heavy chain (4:0), but has a lower relative avidity for Fc than the Ro7, Ro47, and Rel2 lines (A. Davidson, unpublished observations) that have R:S ratios in the CDRs consistent with random mutation. Because single mutations may result in significant differences in both antigenic and idiotypic specificity, an analysis of R:S ratios of mutations per se without information about the binding characteristics ofthe original germline-encoded antibody is not always informative about the role of antigen selection in generating antibodies with altered specificities. In contrast, the FRs have lower than expected R:S ratios, probably reflecting the need for conservation ofFRs in maintaining antibody configuration.
We have reported that the four cell lines using the Humkv325 gene bind a chimeric antibody mutant bearing proline at residues 309-31 1, corresponding to the upper loop of the CH2-CH3 joining area, but do not bind a mutant bearing glycine in the same positions. This specificity was also found for the malignancy associated RFs that are positive for the Wa idiotype and are encoded by the Humkv 325 gene (23) . Although they share this specificity, the three lines that use the same VH (51 P1 ) and VL (Humkv 325) genes, Ro7, Re 12, and Ro47, differ with respect to other specificities. For example, Ro7 binds only to IgG 1, 2, and 4, whereas Ro47 and Re 12 bind to all four IgG isotypes. Ro7 binding to Fc is not inhibited by protein A, whereas Ro47 binding is completely inhibited and Re 12 binding is partially inhibited (23) . These differences must be attributed either to somatic mutations or to differences in the DH, JH, or Jk regions used to encode these RFs.
Our RF cell lines have substantial heterogeneity in portions of the immunoglobulin molecule other than the V gene segments. The heavy chain CDR3 has been reported to contribute to RF specificity (45, 46) . The heavy chain D regions of our panel vary widely in length and sequence and there are no obvious structural features common to all to which we can attribute RF activity. Some of the D regions appear to be fusions of two known D region genes, whereas others cannot be assigned a definite origin (47-49). It is of interest that the D regions of the three Wa-positive RFs are all 11 amino acids long and end with a proline, and that one of the three begins with a glutamine; these features that have been found for other Wa-positive heavy chain D regions (32) . The D regions of the Wa-positive antibodies all share sequence homology with the germline DK4 gene, although the homology at the amino acid level is not obvious. Our panel of RF cell lines also show predominant use ofthe JH4 gene segment. This is the case with the three Wa-positive RFs and is consistent with previous observations that Wa-positive antibodies preferentially use this J region (32) . Analysis of the light chain VJ joins shows that these also are heterogeneous. We did not observe any N region additions leading to long CDR3 regions or acquisition of arginine residues as has been observed for light chain genes derived from rheumatoid synovium cDNA libraries (39, 50) . 2 of the 11 light chains have short CDR3 regions of eight amino acids instead of the usual nine.
It is clear from the findings described here that the possible gene repertoire for encoding RF in our two patients with RA is large, includes multiple genes and gene combinations not found in malignancy-associated RFs, and is not restricted to genes used in the fetal antibody repertoire (51, 52) . In the case ofthe gene families well enough characterized to permit analysis, our findings indicate that diversity arises at least in part from somatic mutation. The role of antigen in selecting these diverse B cells in RA remains unclear. A disturbance of the normal regulation ofRFs or the emergence ofabnormal T cells may account for the recruitment of B cells with different genes and gene combinations and the acquisition of mutations in these genes in RA patients.
